Global social safety, reducing drug related crime.

November 22, 2022 Niet Beschikbaar
[et_pb_section fb_built=”1″ _builder_version=”4.16″ global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_row _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||” theme_builder_area=”post_content”][et_pb_text _builder_version=”4.19.0″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]

Making society and the night-time economy safer, by reducing drink spiking and drug related crime.

This company is an UK-registered company, founded in 2013. Its leading in the development and sale of drug detection solutions, for consumers and law enforcement organizations, to reduce drug-related crimes.

Developing a consumer-focused drug detection category.

  • Currently suppling law enforcement, social venues and consumers with unique and patented drug detection solutions.
  • Working with 10 UK police organizations.

Market opportunity: UK

  • Night time economy venues: UK 42K
  • 42 UK Police forces. 135K active field police officers
  • Social consumers: 33%/22M UK people visit bars/clubs
  • All equivalent channels in key territories re: USA, Europe.

Products:

  • Their patented and bespoke products instantly detect illicit substances used for recreational use or drug related crime.

The problem:

  • Epidemic numbers of drink spiking and drug crime incidents across the UK and Europe.
  • No standard communication or reporting protocols and process in place for victims.
  • There are no standard testing or detection protocols. Inadequate forensic follow up, and lack of prosecutions.
  • No trust law in enforcement to investigate reported drink spiking or drug crime incidents.

Although this is a company registered in the UK it operates from Amsterdam. Tests produced in the UK. If necessary, and important for investors, the company can register in the Netherlands.

Business Model:

  • Subscription model for B2B in return for drug detection tests for venue testing services. 24/7/365 staff training and education.
  • Online, direct-to-consumer for B2C
  • Retail and venue sales of drug tests.

Customer type / profile:

B2B & B2C (Venues, Law enforcement, consumers)

Preferable investor type:

Angel investor; Venture Capitalist; Private Equity

USP’s:

  • Unique and patented drug detection solutions;
  • Subject matter experts in drug related crime;
  • The only instant drug detection test in the world that can detect almost all drugs used for drink spiking and drug crime;
  • Results in 2-3 seconds;
  • No false positives;
  • Completely safe and simple to use.

Social development goals (SDGs) will also be supported.

  • SDG3 for good health and well-being;
  • SGD4 regarding gender equality will be supported;
  • SDG16 regarding peace, justice and strong institutions will also be supported.

Capital amount needed:

£500.000,-

Investment need:

  • Create a B2B subscription, education and accreditation portal and service. (130K)
  • Create B2C online education and test sales platform. (260k)
  • Develop customer-specific delivery systems for existing drug tests. (110k)

 

Sector:

B2B Software; B2C Software; Security

Phase:

Early Growth

Number of founders:

2

Current number of employees:

2

  • One full-time, one part-time.
  • Plan to recruit 3-5 new team members.

Experience:

The founder is an International Business Director with strong brand building, leadership and communications skills. 12 years of experience in this sector.

Science Officer: Former Home Office Forensic Scientist, analytical chemist and toxicologist in criminalistics and drug abuse. 40+ years experience in this sector.

Monthly turnover (current):

£5.833,-

Turnover (forecast) next 12 months:

£530.000,-

Turnover (forecast) months 13 – 24:

£2.000.000,-

Current monthly expenses:

£500,-

Additional information:
The previous investments from founders were £300k+
[/et_pb_text][et_pb_text _builder_version=”4.19.0″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” locked=”off” global_colors_info=”{}” theme_builder_area=”post_content”][/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]